StockData

Central Garden & Pet vs AMCON Distributing

CENT and DIT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CENT and DIT compare

Central Garden & Pet is the larger company, worth 49 times as much as AMCON Distributing ($3.0B against $60.7M).

On earnings, Central Garden & Pet is cheaper: it trades at 17.7× trailing earnings, against 24.7× for AMCON Distributing.

AMCON Distributing grew revenue faster over the last twelve months (10.9% versus −1.2% for Central Garden & Pet).

Central Garden & Pet keeps more of each dollar of sales as profit, with a net margin of 5.4% compared with 0.08% at AMCON Distributing.

AMCON Distributing pays a dividend yielding 0.58%; Central Garden & Pet does not pay one.

Central Garden & Pet scores higher on the StockData Score (13 against 12 for AMCON Distributing), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCENTDIT
Size and price
Market cap$3.0B$60.7M
Share price$47.36$62.24
Change, 1 year49.1%−20.2%
Change, 5 years−11.5%−44.6%
Beta (5Y)0.580.15
Employees6,0001,465
StockData Score
Total score13 (better)12
Valuation score45 (better)
Growth score3 (better)2
Performance score4 (better)0
Health score23 (better)
Dividend score02 (better)
Valuation
P/E17.7× (better)24.7×
P/S1.0×0.0× (better)
P/B1.7×0.5× (better)
EV/EBITDA9.5×3.0× (better)
P/FCF8.6×–
PEG4.00–
FCF yield11.7% (better)−22.5%
Fair value$57.38$218.47
Margin of safety17.5%71.5% (better)
Growth
Revenue growth (TTM)−1.2%10.9% (better)
Revenue growth, 5Y average3.0%13.3% (better)
Net income growth (TTM)20.1%315% (better)
EPS growth (TTM)21.8%306% (better)
EPS growth, 5Y average7.7% (better)−32.7%
Profitability
Gross margin32.5% (better)6.1%
Operating margin8.1% (better)0.44%
Net margin5.4% (better)0.08%
FCF margin11.2% (better)−0.44%
Return on equity10.0% (better)2.1%
Return on invested capital9.5% (better)6.8%
Financial health
Debt / equity0.680.09 (better)
Net debt / EBITDA0.590.44 (better)
Interest coverage4.4× (better)1.4×
Current ratio3.79 (better)2.34
Altman Z-score2.838.67 (better)
Piotroski F-score8 (better)6
Dividends and buybacks
Dividend yield–0.58%
Payout ratio–27.7%
Years of dividend growth–0
Dividend growth, 5Y average–−29.4%
Buyback yield0.98%–
Shareholder yield0.98% (better)0.58%
Ownership
Held by institutions92.9%10.8%
Held by insiders5.1%75.0%
Insider net buying, 12 months−$948K–
Short interest, % of float–0.41%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.